Geode Capital Management, LLC Gbs Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.0 - $0.47 $0 - $217	-462 Reduced 0.4%	115,363 $23,000
Q2 2022 Aug 12, 2022	BUY	$0.56 - $1.31 $1,515 - $3,546	2,707 Added 2.39%	115,825 $76,000
Q1 2022 May 13, 2022	BUY	$0.43 - $1.7 $48,640 - $192,300	113,118 New	113,118 $88,000
Q4 2021 Feb 11, 2022	SELL	$1.26 - $2.45 $136,524 - $265,464	-108,353 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.26 - $4.29 $220,157 - $417,910	97,415 Added 890.61%	108,353 $273,000
Q2 2021 Aug 13, 2021	BUY	$2.65 - $5.72 $28,985 - $62,565	10,938 New	10,938 $43,000

Ticker GBS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,889,900
Description
GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company also focuses on developing COV2 test, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, t...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.